399 related articles for article (PubMed ID: 33982660)
1. Management of cervicofacial lymphatic malformations requires a multidisciplinary approach.
Zobel MJ; Nowicki D; Gomez G; Lee J; Howell L; Miller J; Zeinati C; Anselmo DM
J Pediatr Surg; 2021 May; 56(5):1062-1067. PubMed ID: 33982660
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.
Hill RH; Shiels WE; Foster JA; Czyz CN; Stacey A; Everman KR; Cahill KV
Ophthalmic Plast Reconstr Surg; 2012; 28(2):119-25. PubMed ID: 22366666
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic malformations in children: treatment outcomes of sclerotherapy in a large cohort.
Bouwman FCM; Kooijman SS; Verhoeven BH; Schultze Kool LJ; van der Vleuten CJM; Botden SMBI; de Blaauw I
Eur J Pediatr; 2021 Mar; 180(3):959-966. PubMed ID: 33051716
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.
Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
J Neurointerv Surg; 2014 Nov; 6(9):691-4. PubMed ID: 24153336
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience.
Cahill AM; Nijs E; Ballah D; Rabinowitz D; Thompson L; Rintoul N; Hedrick H; Jacobs I; Low D
J Pediatr Surg; 2011 Nov; 46(11):2083-95. PubMed ID: 22075337
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous sclerotherapy of microcystic lymphatic malformations: the use of an innovative gravity-dependent technique.
Berenstein A; Bazil MJ; Sorscher M; Blei F; De Leacy R; Shigematsu T; Waner M; Fifi JT
J Neurointerv Surg; 2023 Mar; 15(3):272-275. PubMed ID: 35347057
[TBL] [Abstract][Full Text] [Related]
8. Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children.
Abdelaziz O; Hassan F; Elessawy K; Emad-Eldin S; Essawy RE
Cardiovasc Intervent Radiol; 2019 Mar; 42(3):433-440. PubMed ID: 30488306
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy.
Shergill A; John P; Amaral JG
Pediatr Radiol; 2012 Sep; 42(9):1080-8. PubMed ID: 22648390
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation.
Chaudry G; Guevara CJ; Rialon KL; Kerr C; Mulliken JB; Greene AK; Fishman SJ; Boyer D; Alomari AI
Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1476-81. PubMed ID: 24938907
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Bleomycin Slow Infusion Sclerotherapy Using a Syringe Pump for Microcystic and Mixed Lymphatic Malformations.
Cha JG; Lee J; Lee SY; Chung HY; Lee SJ; Huh S; Kim JY; Hong J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1288-1294. PubMed ID: 35864208
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations.
Farnoosh S; Don D; Koempel J; Panossian A; Anselmo D; Stanley P
Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):883-887. PubMed ID: 25887132
[TBL] [Abstract][Full Text] [Related]
13. The Management of Giant Cerviofacial Lymphatic Malformations in Children.
Li W; Xu H; Zhao L; Li X
J Craniofac Surg; 2019 Sep; 30(6):e553-e555. PubMed ID: 30985347
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin sclerotherapy for lymphatic malformation after unsuccessful surgical excision: case report.
Vlahovic A; Gazikalovic A; Adjic O
Acta Otorhinolaryngol Ital; 2015 Oct; 35(5):365-7. PubMed ID: 26824921
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin sclerotherapy in lymphangiomas of the head and neck region: a prospective study.
Tiwari P; Pandey V; Bera RN; Sharma SP; Chauhan N
Int J Oral Maxillofac Surg; 2021 May; 50(5):619-626. PubMed ID: 33059994
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy.
Peters DA; Courtemanche DJ; Heran MKS; Ludemann JP; Prendiville JS
Plast Reconstr Surg; 2006 Nov; 118(6):1441-1446. PubMed ID: 17051116
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
[TBL] [Abstract][Full Text] [Related]
18. [Management of lymphatic malformations in oral and maxillofacial regions: the rationale according to the new classification].
Zheng JW; Qin ZP; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2005 Dec; 14(6):553-6. PubMed ID: 16400476
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous sclerotherapy of lymphatic malformations with doxycycline.
Burrows PE; Mitri RK; Alomari A; Padua HM; Lord DJ; Sylvia MB; Fishman SJ; Mulliken JB
Lymphat Res Biol; 2008; 6(3-4):209-16. PubMed ID: 19093794
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous treatment of lymphatic malformations.
Shiels WE; Kang DR; Murakami JW; Hogan MJ; Wiet GJ
Otolaryngol Head Neck Surg; 2009 Aug; 141(2):219-24. PubMed ID: 19643255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
